Are You a Healthcare Professional interested in VEXAS Syndrome?

This website is intended to provide information about the PAXIS clinical trial for patients with VEXAS Syndrome.

Yes No

The PAXIS clinical trial is a randomized, double-blind, placebo-controlled phase 2 study of pacritinib in patients with VEXAS Syndrome.

This website uses cookies. By continuing to use this website, you consent to our use of these cookies.

Read more about
our use of cookies